Literature DB >> 1633877

Identification of a novel transthyretin variant (Val30----Leu) associated with familial amyloidotic polyneuropathy.

M Nakazato1, S Ikeda, K Shiomi, S Matsukura, K Yoshida, H Shimizu, T Atsumi, K Kangawa, H Matsuo.   

Abstract

A novel variant transthyretin which contains a leucine-for-valine substitution at position 30 was isolated and identified in the serum of a patient with familial amyloidotic polyneuropathy (FAP). The amino acid substitution was proven to result from a guanine-to-cytosine change at the first base of codon 30 located in exon 2 in the mutated transthyretin gene by restriction fragment length analysis on the amplified transthyretin gene using Cfr13 I. The study indicates that the point mutation of the transthyretin gene is a cause of the disorder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633877     DOI: 10.1016/0014-5793(92)81001-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Coexistence of type I familial amyloid polyneuropathy and spinocerebellar ataxia type 1. Clinical and genetic studies of a Japanese family.

Authors:  S Ikeda; N Yanagisawa; N Hanyu; K Furihata; T Kobayashi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

2.  Structure of Met30 variant of transthyretin and its amyloidogenic implications.

Authors:  C J Terry; A M Damas; P Oliveira; M J Saraiva; I L Alves; P P Costa; P M Matias; Y Sakaki; C C Blake
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.